Cigna Group $CI Shares Sold by First American Trust FSB

First American Trust FSB lessened its position in shares of Cigna Group (NYSE:CI) by 9.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,922 shares of the health services provider’s stock after selling 1,865 shares during the quarter. First American Trust FSB’s holdings in Cigna Group were worth $4,932,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CI. Norges Bank acquired a new position in shares of Cigna Group during the 4th quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Cigna Group by 13,333.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after buying an additional 3,141,844 shares during the last quarter. Capital Research Global Investors raised its stake in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after buying an additional 753,865 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 0.5%

CI opened at $296.34 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $78.39 billion, a price-to-earnings ratio of 12.56, a price-to-earnings-growth ratio of 1.14 and a beta of 0.28. The business has a 50-day moving average of $281.36 and a two-hundred day moving average of $277.76. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is 26.45%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Jefferies Financial Group cut their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Royal Bank Of Canada boosted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Wells Fargo & Company boosted their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $310.00 to $304.00 in a research note on Tuesday, May 26th. Finally, Robert W. Baird set a $337.00 target price on shares of Cigna Group in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $338.80.

Insider Buying and Selling

In other Cigna Group news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.